New strategy heads at Genmab and Codagenix

Genmab A/S (NASDAQ:GMAB; CSE:GMAB) promoted Martine van Vugt to chief strategy officer and EVP, effective March 29. van Vugt joined in 2001 as a program manager, and was most recently SVP of corporate strategy and planning. 

Viral vaccines and immuno-oncology company Codagenix Inc. hired Kimber Poffenberger as chief strategy officer. Poffenberger was principal consultant at Poffenberger Regulatory Resources, before which she was SVP, head of global regulatory affairs at Alvotech Holdings S.A. (NASDAQ:ALVO; XICE:ALVO). ...